Health
Gout drug could reduce Covid hospital stays, new research finds – The Guardian
Colchicine also found to reduce need for extra oxygen and has potential to be used in outpatient settings
A cheap drug normally used to treat gout has been found to have the potential to significantly reduce hospital stays among Covid-19 patients and the need for extra oxygen.
The results of new research into colchicine conducted in Brazil come after an international trial published on Wednesday found that it reduced hospitalisations and deaths among Covid-19 patients by more than 20%.
Colchicine, which is used to treat rheumatic diseases, was hailed by researchers as having the potential to be the…
-
General24 hours agoBill Shorten believes Peter Dutton’s work-from-home policy backflip will cost him at election time
-
Noosa News23 hours agoAudit slams state school fees
-
Noosa News12 hours agoCity of Moreton Bay throws homeless people’s tents into garbage trucks
-
Noosa News14 hours agoTourism at the crossroads | Noosa Today